Stay updated on CMP-001 Combo With Nivolumab in Melanoma Clinical Trial
Sign up to get notified when there's something new on the CMP-001 Combo With Nivolumab in Melanoma Clinical Trial page.

Latest updates to the CMP-001 Combo With Nivolumab in Melanoma Clinical Trial page
- Check2 days agoNo Change Detected
- Check10 days agoChange DetectedThe webpage has undergone significant changes, including the removal of detailed descriptions of a clinical study for melanoma treatment and the addition of collaborators and a new version revision. The study's focus on the combination of nivolumab and CMP-001 for melanoma patients has been altered, with key details about the study phases and patient criteria removed.SummaryDifference44%
- Check17 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4, and a date has been added for February 7, 2025, while a date for March 25, 2025, has been removed.SummaryDifference0.3%
- Check24 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check60 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1.0%
- Check75 days agoChange DetectedThe webpage has updated its content to reflect new statistics on patient responses and survival rates, while also removing outdated data. Additionally, there is a notice regarding heavy traffic affecting service performance.SummaryDifference5%
- Check82 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.1%
Stay in the know with updates to CMP-001 Combo With Nivolumab in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CMP-001 Combo With Nivolumab in Melanoma Clinical Trial page.